QUOTED. 1 December. Rob Field.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
“With viruses that mutate regularly, the genetic material changes year on year, so does the protein on the surface of the virus. What doesn’t change is the ability of the virus to bind to sugars on animal cells. That’s where we come in – [we looked at how] we can exploit that recognition of sugars. In the short term our focus is on exploiting the sugar-protein interactions for the development of diagnostics.” – Rob Field, CEO, Iceni Diagnostics
- Find out more: COVID-19: Could Lateral Flow Test Using Glycan Recognition Be A Rapid Testing Breakthrough?
Click here for a free trial of Medtech Insight